Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Ocular Therapeut
(NQ:
OCUL
)
6.560
+0.310 (+4.96%)
Streaming Delayed Price
Updated: 2:03 PM EDT, Jun 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ocular Therapeut
< Previous
1
2
3
4
5
6
7
Next >
Ocular Therapeutix™ Announces Second Quarter 2021 Preliminary Net Product Revenue of $11.7 Million
July 22, 2021
From
Ocular Therapeutix, Inc.
Via
Business Wire
Ocular Therapeutix™ and Mosaic Biosciences Enter into Strategic Discovery Collaboration Targeting the Treatment of Dry Age-Related Macular Degeneration
June 29, 2021
From
Ocular Therapeutix, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
June 08, 2021
Gainers Aethlon Medical (NASDAQ:AEMD) sto...
Via
Benzinga
Ocular Therapeutix™ to Participate at Three Upcoming Investor Conferences
May 26, 2021
From
Ocular Therapeutix, Inc.
Via
Business Wire
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
May 01, 2021
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...
Via
Benzinga
Exposures
Product Safety
Ocular Therapeutix™ Reports First Quarter 2021 Financial Results and Business Update
May 05, 2021
From
Ocular Therapeutix, Inc.
Via
Business Wire
CORRECTING and REPLACING Ocular Therapeutix™ To Present Pre-Clinical and Clinical Data at the 2021 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
May 03, 2021
From
Ocular Therapeutix, Inc.
Via
Business Wire
Ocular Therapeutix™ Fulfills Post-Marketing Approval Requirements for ReSure® Sealant
May 03, 2021
From
Ocular Therapeutix, Inc.
Via
Business Wire
The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues
May 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
65 Biggest Movers From Yesterday
April 30, 2021
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) jumped 33.1% to settle at $3.34 on Thursday as the company said it has been named as sponsor related to 4 SPACs. Takung Art Co., Ltd. (...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
April 29, 2021
Gainers Galera Therapeutics (NASDAQ:GRTX) stock rose 21.78% to $8.05 during Thursday's regular session. As of 12:32 EST, Galera Therapeutics's stock is trading at...
Via
Benzinga
54 Stocks Moving In Thursday's Mid-Day Session
April 29, 2021
Gainers Willamette Valley Vineyards, Inc. (NASDAQ: WVVI) climbed 40.5% to $14.39. Dolphin Entertainment, Inc. (NASDAQ: DLPN) shares gained 23.1% to $14.14. Dolphin Entertainment...
Via
Benzinga
Ocular Therapeutix™ To Present Pre-Clinical and Clinical Data at the 2021 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
April 29, 2021
From
Ocular Therapeutix, Inc.
Via
Business Wire
Ocular Therapeutix™ To Report First Quarter 2021 Financial Results
April 28, 2021
From
Ocular Therapeutix, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.